Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8311)
All Articles published online
|
Dec 21, 2011 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abu-Mouch S, Fireman Z, Jarchovsky J, Zeina AR, Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 2011; 17(47): 5184-5190 [PMID: 22215943 DOI: 10.3748/wjg.v17.i47.5184] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i47/5184.htm |
| Number | Citing Articles |
| 1 |
Monika Rau, Katharina Baur, Andreas Geier. Host Genetic Variants in the Pathogenesis of Hepatitis C. Viruses 2012; 4(12): 3281 doi: 10.3390/v4123281
|
| 2 |
Christian M. Lange, Stephanie Bibert, Zoltan Kutalik, Philippe Burgisser, Andreas Cerny, Jean-Francois Dufour, Andreas Geier, Tilman J. Gerlach, Markus H. Heim, Raffaele Malinverni, Francesco Negro, Stephan Regenass, Klaus Badenhoop, Jörg Bojunga, Christoph Sarrazin, Stefan Zeuzem, Tobias Müller, Thomas Berg, Pierre-Yves Bochud, Darius Moradpour, Stephen J. Polyak. A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C. PLoS ONE 2012; 7(7): e40159 doi: 10.1371/journal.pone.0040159
|
| 3 |
Goran Bjelakovic, Dimitrinka Nikolova, Marko Bjelakovic, Christian Gluud. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2017; 2017(11) doi: 10.1002/14651858.CD011564.pub2
|
| 4 |
Yoshie Omori‐Mizuno, Nobuaki Nakayama, Mie Inao, Junji Funyu, Shinichi Asabe, Kengo Tomita, Kou Nishikawa, Yasuo Hosoda, Masahiko Tanaka, Yoshiaki Hashimoto, Koji Yakabi, Yohei Koshima, Satoshi Mochida. Randomized study comparing vitamin D3 and 1α‐Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C. Journal of Gastroenterology and Hepatology 2015; 30(9): 1384 doi: 10.1111/jgh.12949
|
| 5 |
A. R. Yasmin, M. N. Sohaimi, S. N. A. Azaman, S. H. Nur-Fazila, F. M. A. Amirul. Sustainable Use of Feed Additives in Livestock. 2023; : 327 doi: 10.1007/978-3-031-42855-5_12
|
| 6 |
Christian M. Lange, Jérôme Gouttenoire, François H. T. Duong, Kenichi Morikawa, Markus H. Heim, Darius Moradpour. Vitamin D Receptor and Jak–STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN-α. The Journal of Immunology 2014; 192(12): 6037 doi: 10.4049/jimmunol.1302296
|
| 7 |
Savita Budhwar, Kashika Sethi, Manali Chakraborty. A Rapid Advice Guideline for the Prevention of Novel Coronavirus Through Nutritional Intervention. Current Nutrition Reports 2020; 9(3): 119 doi: 10.1007/s13668-020-00325-1
|
| 8 |
Edmondo Falleti, Sara Cmet, Carlo Fabris, Giovanna Fattovich, Annarosa Cussigh, Davide Bitetto, Elisa Ceriani, Ilaria Lenisa, Denis Dissegna, Donatella Ieluzzi, Anna Rostello, Mario Pirisi, Pierluigi Toniutto, Golo Ahlenstiel. Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C. PLoS ONE 2013; 8(11): e80764 doi: 10.1371/journal.pone.0080764
|
| 9 |
Yuan‐Ping Han, Ming Kong, Sujun Zheng, Yan Ren, Longdon Zhu, Hongbo Shi, Zhongping Duan. Vitamin D in liver diseases: From mechanisms to clinical trials. Journal of Gastroenterology and Hepatology 2013; 28(S1): 49 doi: 10.1111/jgh.12016
|
| 10 |
Sunil Gupta, Scott A. Read, Nicholas A. Shackel, Lionel Hebbard, Jacob George, Golo Ahlenstiel. The Role of Micronutrients in the Infection and Subsequent Response to Hepatitis C Virus. Cells 2019; 8(6): 603 doi: 10.3390/cells8060603
|
| 11 |
H.‐B. Kim, S.‐K. Myung, Y.‐J. Lee, B.‐J. Park. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta‐analysis of randomised controlled trials. Journal of Human Nutrition and Dietetics 2018; 31(2): 168 doi: 10.1111/jhn.12503
|
| 12 |
Mónica García-Álvarez, Daniel Pineda-Tenor, María A. Jiménez-Sousa, Amanda Fernández-Rodríguez, María Guzmán-Fulgencio, Salvador Resino. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta-analysis. Hepatology 2014; 60(5): 1541 doi: 10.1002/hep.27281
|
| 13 |
Gerome V. Escota, Sara Cross, William G. Powderly. Vitamin D and Calcium Abnormalities in the HIV-Infected Population. Endocrinology and Metabolism Clinics of North America 2014; 43(3): 743 doi: 10.1016/j.ecl.2014.05.005
|
| 14 |
Tudor Lucian Pop, Claudia Sîrbe, Gabriel Benţa, Alexandra Mititelu, Alina Grama. The Role of Vitamin D and Vitamin D Binding Protein in Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(18): 10705 doi: 10.3390/ijms231810705
|
| 15 |
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the Treatment of HIV-/HCV-Coinfected Patients. Pharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
|
| 16 |
Mohamed E. Ali, Hamada M. Halby, Mamdouh Yones Ali, Elham Ahmed Hassan, Mohamed A. El-Mokhtar, Ibrahim M. Sayed, Marwa M. Thabet, Magdy Fouad, Ahmed M. El-Ashmawy, Zainab Gaber Mahran. Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents. Viruses 2021; 13(10): 2008 doi: 10.3390/v13102008
|
| 17 |
Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji. Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/859697
|
| 18 |
Somayeh Khanjani, Sareh Khanjani. Effect of Conjugated Estrogen in Stress Urinary Incontinence in Women with Menopause. International Journal of Clinical Medicine 2017; 8(06): 375 doi: 10.4236/ijcm.2017.86035
|
| 19 |
Christopher R. Sudfeld, Ferdinand Mugusi, Said Aboud, Tumaini J. Nagu, Molin Wang, Wafaie W. Fawzi. Efficacy of vitamin D3 supplementation in reducing incidence of pulmonary tuberculosis and mortality among HIV-infected Tanzanian adults initiating antiretroviral therapy: study protocol for a randomized controlled trial. Trials 2017; 18(1) doi: 10.1186/s13063-017-1819-5
|
| 20 |
Paula Iruzubieta, Álvaro Terán, Javier Crespo, Emilio Fábrega. Vitamin D deficiency in chronic liver disease. World Journal of Hepatology 2014; 6(12): 901-915 doi: 10.4254/wjh.v6.i12.901
|
| 21 |
Henry Lik-Yuen Chan, Magdy Elkhashab, Huy Trinh, Won Young Tak, Xiaoli Ma, Wan-Long Chuang, Yoon Jun Kim, Eduardo B. Martins, Lanjia Lin, Phillip Dinh, Prista Charuworn, Graham R. Foster, Patrick Marcellin. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. Journal of Hepatology 2015; 63(5): 1086 doi: 10.1016/j.jhep.2015.06.025
|
| 22 |
Ioanna Aggeletopoulou, Konstantinos Thomopoulos, Athanasia Mouzaki, Christos Triantos. Vitamin D–VDR Novel Anti-Inflammatory Molecules—New Insights into Their Effects on Liver Diseases. International Journal of Molecular Sciences 2022; 23(15): 8465 doi: 10.3390/ijms23158465
|
| 23 |
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. Discontinued drugs in 2012 – 2013: hepatitis C virus infection. Expert Opinion on Investigational Drugs 2015; 24(2): 239 doi: 10.1517/13543784.2015.982274
|
| 24 |
Ivan Gentile, Nicola Coppola, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus. Expert Opinion on Investigational Drugs 2014; 23(9): 1211 doi: 10.1517/13543784.2014.921680
|
| 25 |
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Nicola Coppola, Guglielmo Borgia. GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection. Expert Review of Anti-infective Therapy 2014; 12(10): 1179 doi: 10.1586/14787210.2014.945432
|
| 26 |
Asako Murayama, Hiroshi Saitoh, Akiko Takeuchi, Norie Yamada, Takuya Matsumura, Masaaki Shiina, Masamichi Muramatsu, Takaji Wakita, Michio Imawari, Takanobu Kato. Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein. Antiviral Research 2018; 160: 55 doi: 10.1016/j.antiviral.2018.10.014
|
| 27 |
Nasrin Sharifi, Reza Amani, Eskandar Hajiani, Bahman Cheraghian. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine 2014; 47(1): 70 doi: 10.1007/s12020-014-0336-5
|
| 28 |
Ranil Jayawardena, Piumika Sooriyaarachchi, Michail Chourdakis, Chandima Jeewandara, Priyanga Ranasinghe. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(4): 367 doi: 10.1016/j.dsx.2020.04.015
|
| 29 |
Adeeb H. Rahman, Andrea D. Branch. Vitamin D for your patients with chronic hepatitis C?. Journal of Hepatology 2013; 58(1): 184 doi: 10.1016/j.jhep.2012.07.026
|
| 30 |
Yo-ichi Ishida, Masahiko Takeshita, Hiroaki Kataoka. Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism. World Journal of Hepatology 2014; 6(12): 870-879 doi: 10.4254/wjh.v6.i12.870
|
| 31 |
Dina L Halegoua-De Marzio, Jonathan M Fenkel. Complementary and alternative medications in hepatitis C infection. World Journal of Hepatology 2014; 6(1): 9-16 doi: 10.4254/wjh.v6.i1.9
|
| 32 |
Repetitorium Für die Facharztprüfung Innere Medizin. 2017; : 185 doi: 10.1016/B978-3-437-23316-6.00004-5
|
| 33 |
Asako Murayama, Takanobu Kato. Hormones, Regulators and Viruses. Vitamins and Hormones 2021; 117: 227 doi: 10.1016/bs.vh.2021.06.006
|
| 34 |
Kanika Khanna, Sukhmeen Kaur Kohli, Ravdeep Kaur, Abhay Bhardwaj, Vinay Bhardwaj, Puja Ohri, Anket Sharma, Ajaz Ahmad, Renu Bhardwaj, Parvaiz Ahmad. Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle. Phytomedicine 2021; 85: 153361 doi: 10.1016/j.phymed.2020.153361
|
| 35 |
Tawhida Y Abdel-Ghaffar, Mostafa M Sira, Suzan El Naghi. Hepatitis C genotype 4: The past, present, and future. World Journal of Hepatology 2015; 7(28): 2792-2810 doi: 10.4254/wjh.v7.i28.2792
|
| 36 |
Goran Bjelakovic, Lise Lotte Gluud, Dimitrinka Nikolova, Kate Whitfield, Jørn Wetterslev, Rosa G Simonetti, Marija Bjelakovic, Christian Gluud. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database of Systematic Reviews 2014; 2014(1) doi: 10.1002/14651858.CD007470.pub3
|
| 37 |
Kristine R Broglio, Eric S Daar, Melanie Quintana, Yong Yuan, Anupama Kalsekar, Brad Spellberg, Roger J Lewis, Dane van den Akker, Michelle A Detry, Trong Le, Scott M Berry. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens. Journal of Comparative Effectiveness Research 2015; 4(2): 101 doi: 10.2217/cer.14.69
|
| 38 |
Maheen Siddiqui, Judhell S. Manansala, Hana A. Abdulrahman, Gheyath K. Nasrallah, Maria K. Smatti, Nadin Younes, Asmaa A. Althani, Hadi M. Yassine. Immune Modulatory Effects of Vitamin D on Viral Infections. Nutrients 2020; 12(9): 2879 doi: 10.3390/nu12092879
|
| 39 |
M. Kizilgul, O. Ozcelik, T. Delibasi. Bone health and vitamin D status in alcoholic liver disease. Indian Journal of Gastroenterology 2016; 35(4): 253 doi: 10.1007/s12664-016-0652-1
|
| 40 |
Carlo Basile, Vincent Brandenburg, Pablo A. Ureña Torres. Vitamin D in Chronic Kidney Disease. 2016; : 465 doi: 10.1007/978-3-319-32507-1_28
|
| 41 |
Chenguang Wang, Yukun Guan, Mengze Lv, Rui Zhang, Zhaoying Guo, Xiaoming Wei, Xiaoxia Du, Jing Yang, Tong Li, Yi Wan, Xiaodong Su, Xiaojun Huang, Zhengfan Jiang. Manganese Increases the Sensitivity of the cGAS-STING Pathway for Double-Stranded DNA and Is Required for the Host Defense against DNA Viruses. Immunity 2018; 48(4): 675 doi: 10.1016/j.immuni.2018.03.017
|
| 42 |
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn. Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study. The Korean Journal of Internal Medicine 2020; 35(5): 1074 doi: 10.3904/kjim.2018.273
|
| 43 |
Stephen Malnick, Yaakov Maor, Ehud Melzer, Sari Tal. Chronic Hepatitis C in the Aged: Much Ado About Nothing or Nothing to Do?. Drugs & Aging 2014; 31(5): 339 doi: 10.1007/s40266-014-0170-8
|
| 44 |
Michio Imawari. Does vitamin D supplementation improve sustained virological response in cirrhotic patients with hepatitis C virus genotype 1b and high viral load?. Hepatology Research 2014; 44(13): 1265 doi: 10.1111/hepr.12328
|
| 45 |
Choongho Lee. Controversial Effects of Vitamin D and Related Genes on Viral Infections, Pathogenesis, and Treatment Outcomes. Nutrients 2020; 12(4): 962 doi: 10.3390/nu12040962
|
| 46 |
S. Yokoyama, S. Takahashi, Y. Kawakami, C. N. Hayes, H. Kohno, H. Kohno, K. Tsuji, Y. Aisaka, S. Kira, K. Yamashina, M. Nonaka, T. Moriya, M. Kitamoto, S. Aimitsu, T. Nakanishi, H. Kawakami, K. Chayama. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial. Journal of Viral Hepatitis 2014; 21(5): 348 doi: 10.1111/jvh.12146
|
| 47 |
Elżbieta Karczmarewicz, Edyta Czekuć-Kryśkiewicz, Paweł Płudowski. Effect of vitamin D status on pharmacological treatment efficiency. Dermato-Endocrinology 2013; 5(1): 1 doi: 10.4161/derm.25531
|
| 48 |
Paola Di Carlo, Lucia Siracusa, Giovanni Mazzola, Piero Colletti, Maurizio Soresi, Lydia Giannitrapani, Valentina Li Vecchi, Giuseppe Montalto. Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review. International Journal of Endocrinology 2015; 2015: 1 doi: 10.1155/2015/969040
|
| 49 |
Elzbieta Karczmarewicz, Edyta Czekuc-Kryskiewicz, Paweł Płudowski. Effect of vitamin D status on pharmacological treatment efficiency. Dermato-Endocrinology 2013; 5(2): 299 doi: 10.4161/derm.25279
|
| 50 |
John F. Arboleda, Geysson J. Fernandez, Silvio Urcuqui-Inchima. Vitamin D-mediated attenuation of miR-155 in human macrophages infected with dengue virus: Implications for the cytokine response. Infection, Genetics and Evolution 2019; 69: 12 doi: 10.1016/j.meegid.2018.12.033
|
| 51 |
Kessarin Thanapirom, Sirinporn Suksawatamnuay, Wattana Sukeepaisarnjaroen, Pisit Tangkijvanich, Sombat Treeprasertsuk, Panarat Thaimai, Rujipat Wasitthankasem, Yong Poovorawan, Piyawat Komolmit. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0613-x
|
| 52 |
Haijuan Mou, Fengying Yang, Jianqin Zhou, Cuixia Bao. Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6663
|
| 53 |
P. O. Lang, N. Samaras, D. Samaras, R. Aspinall. How important is vitamin D in preventing infections?. Osteoporosis International 2013; 24(5): 1537 doi: 10.1007/s00198-012-2204-6
|
| 54 |
Omar A Masri, Jean M Chalhoub, Ala I Sharara. Role of vitamins in gastrointestinal diseases. World Journal of Gastroenterology 2015; 21(17): 5191-5209 doi: 10.3748/wjg.v21.i17.5191
|
| 55 |
Grace Lai-Hung Wong, Henry Lik-Yuen Chan, Hoi-Yun Chan, Chi-Hang Tse, Angel Mei-Ling Chim, Angeline Oi-Shan Lo, Vincent Wai-Sun Wong. Adverse Effects of Vitamin D Deficiency on Outcomes of Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 2015; 13(4): 783 doi: 10.1016/j.cgh.2014.09.050
|
| 56 |
Hao-zhi Fan, Ru Zhang, Ting Tian, Yu-ling Zhong, Meng-ping Wu, Chao-nan Xie, Jing-jing Yang, Peng Huang, Rong-bin Yu, Yun Zhang, Jie Wang. CYP24A1 genetic variants in the vitamin D metabolic pathway are involved in the outcomes of hepatitis C virus infection among high-risk Chinese population. International Journal of Infectious Diseases 2019; 84: 80 doi: 10.1016/j.ijid.2019.04.032
|
| 57 |
Kamal Kant Sharma, Uttara Partap, Nerges Mistry, Yogesh Marathe, Molin Wang, Sanaa Shaikh, Pradeep D'Costa, Gaurav Gupta, Sabri Bromage, Elena C Hemler, Kevin C Kain, Yatin Dholakia, Wafaie W Fawzi. Randomised trial to determine the effect of vitamin D and zinc supplementation for improving treatment outcomes among patients with COVID-19 in India: trial protocol. BMJ Open 2022; 12(8): e061301 doi: 10.1136/bmjopen-2022-061301
|
| 58 |
Hans L Tillmann. Vitamins? The magic bullet against hepatitis C. Expert Review of Anti-infective Therapy 2012; 10(11): 1273 doi: 10.1586/eri.12.127
|
| 59 |
E. I. Kukhareva, P. P. Ogurtsov. The influence of correction of vitamin D deficiency on the formation of the stable virological
response during therapy of genotype-1 chronic hepatitis C with PEGylated interferon-alpha-2 and ribavirin. Clinical Medicine (Russian Journal) 2017; 95(5): 438 doi: 10.18821/0023-2149-2017-95-5-438-444
|
| 60 |
Anchalee Avihingsanon, Salyavit Jitmitraparp, Pisit Tangkijvanich, Reshmie A. Ramautarsing, Tanakorn Apornpong, Supunee Jirajariyavej, Opass Putcharoen, Sombat Treeprasertsuk, Srunthron Akkarathamrongsin, Yong Poovorawan, Gail V Matthews, Joep MA Lange, Kiat Ruxrungtham. Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels. Journal of Gastroenterology and Hepatology 2014; 29(9): 1706 doi: 10.1111/jgh.12613
|
| 61 |
Harendran Elangovan, Sarinder Chahal, Jenny E. Gunton. Vitamin D in liver disease: Current evidence and potential directions. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(4): 907 doi: 10.1016/j.bbadis.2017.01.001
|
| 62 |
Jade Ghosn, Jean-Paul Viard. Vitamine D et infections. La Presse Médicale 2013; 42(10): 1371 doi: 10.1016/j.lpm.2013.07.009
|
| 63 |
Georgios Grammatikos, Christian Lange, Simone Susser, Susanne Schwendy, Nektarios Dikopoulos, Peter Buggisch, Jens Encke, Gerlinde Teuber, Tobias Goeser, Robert Thimme, Hartwig Klinker, Wulf O. Boecher, Ewert Schulte-Frohlinde, Marissa Penna-Martinez, Klaus Badenhoop, Stefan Zeuzem, Thomas Berg, Christoph Sarrazin, Kostas Pantopoulos. Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients. PLoS ONE 2014; 9(2): e87974 doi: 10.1371/journal.pone.0087974
|
| 64 |
Ivan Gentile, Antonio Riccardo Buonomo, Emanuela Zappulo, Guglielmo Borgia. Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?. Expert Review of Anti-infective Therapy 2014; 12(7): 763 doi: 10.1586/14787210.2014.929497
|
| 65 |
Christian Wejse, Cecilie Blenstrup Patsche. Extraskeletal Effects of Vitamin D. Contemporary Endocrinology 2018; : 57 doi: 10.1007/978-3-319-73742-3_3
|
| 66 |
Xiaowei He, Cheng Xu, Zheng-Hong Lu, Xiao-Zheng Fang, Juan Tan, Yingjian Song. Low serum 25-hydroxyvitamin D levels are associated with liver injury markers in the US adult population. Public Health Nutrition 2020; 23(16): 2915 doi: 10.1017/S1368980020000348
|
| 67 |
Andrea D. Branch, Burc Barin, Adeeb Rahman, Peter Stock, Thomas D. Schiano. Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: Multi-site study. Liver Transplantation 2014; 20(2): 156 doi: 10.1002/lt.23784
|
| 68 |
Kambiz Yazdanpanah, Farshad Sheykhesmeeili, Baran Parhizkar, Abbas Ghasemi. Serum Vitamin D Levels and Severity of Liver Dysfunction in Cirrhotic Patients. International Journal of Clinical Medicine 2017; 8(06): 402 doi: 10.4236/ijcm.2017.86038
|
| 69 |
Neta Gotlieb, Irena Tachlytski, Yelena Lapidot, Maya Sultan, Michal Safran, Ziv Ben-Ari. Hepatitis B virus downregulates vitamin D receptor levels in hepatoma cell lines, thereby preventing vitamin D-dependent inhibition of viral transcription and production. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0055-0
|
| 70 |
Wael Abdel-Razek, Imam Waked. Optimal Management of HCV Genotype 4. Current Hepatology Reports 2014; 13(4): 286 doi: 10.1007/s11901-014-0243-5
|
| 71 |
Sirio Fiorino, Maddalena Zippi, Claudio Gallo, Debora Sifo, Sergio Sabbatani, Roberto Manfredi, Edoardo Rasciti, Leonardo Rasciti, Enrico Giampieri, Ivan Corazza, Paolo Leandri, Dario de Biase. The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities. British Journal of Nutrition 2021; 125(3): 275 doi: 10.1017/S0007114520002913
|
| 72 |
Matthew T. Kitson, Peter Button, Stuart K. Roberts. Reply to: “Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection”. Journal of Hepatology 2013; 59(1): 194 doi: 10.1016/j.jhep.2013.03.001
|
| 73 |
Zongmei Zhang, Xiaoting Yu, Xia Fang, Aibin Liang, Zhang Yu, Pan Gu, Yu Zeng, Jian He, Hailong Zhu, Shuai Li, Desheng Fan, Fei Han, Lanjing Zhang, Xianghua Yi. Preventive effects of vitamin D treatment on bleomycin-induced pulmonary fibrosis. Scientific Reports 2015; 5(1) doi: 10.1038/srep17638
|
| 74 |
Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Giuseppe Castaldo, Guglielmo Borgia. Ledipasvir: a novel synthetic antiviral for the treatment of HCV infection. Expert Opinion on Investigational Drugs 2014; 23(4): 561 doi: 10.1517/13543784.2014.892581
|
| 75 |
Vandana Kalia, Surojit Sarkar. Feldman and Pike's Vitamin D. 2024; : 1011 doi: 10.1016/B978-0-323-91338-6.00045-8
|
| 76 |
Tomomi Okubo, Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Hiroshi Abe, Kai Yoshizawa, Taeang Arai, Ai Nakagawa, Norio Itokawa, Chisa Kondo, Yoshio Aizawa, Katsuhiko Iwakiri. Association between vitamin D deficiency and pre‐existing resistance‐associated hepatitis C virus NS5A variants. Hepatology Research 2017; 47(7): 641 doi: 10.1111/hepr.12784
|
| 77 |
Hsuan-Wei Chen, Yi-Lin Chiu, Tsai-Yuan Hsieh, Peng-Jen Chen, Tien-Yu Huang, Hsuan-Hwai Lin, Yu-Lueng Shih, Jung-Chun Lin. Relationships Between Vitamin D Status and Cytokine: Results from Interferon-Based Therapy in Non-Cirrhotic, Treatment-Naïve Patients with Chronic Hepatitis C Infection. Journal of Inflammation Research 2020; : 1207 doi: 10.2147/JIR.S283768
|
| 78 |
Matthew T. Kitson, Christoph Sarrazin, Pierluigi Toniutto, Guy D. Eslick, Stuart K. Roberts. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: A systematic review and meta-analysis. Journal of Hepatology 2014; 61(6): 1247 doi: 10.1016/j.jhep.2014.08.004
|
| 79 |
Livia Salmi, Matteo Nazzareno Barbaglia, Carlo Smirne, Sara Bianco, Giulia Guaschino, Maria Grazia Stella Crobu, Rosalba Minisini, Mario Pirisi. Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis. The Open Rheumatology Journal 2018; 12(1): 279 doi: 10.2174/1874312901812010279
|
| 80 |
M. Mrityunjaya, V. Pavithra, R. Neelam, P. Janhavi, P. M. Halami, P. V. Ravindra. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.570122
|
| 81 |
P.-O. Lang. La vitamine D : effets de son déficit et de sa supplémentation sur l’incidence des infections. NPG Neurologie - Psychiatrie - Gériatrie 2013; 13(74): 79 doi: 10.1016/j.npg.2012.11.003
|
| 82 |
Matthew T. Kitson, Gregory J. Dore, Jacob George, Peter Button, Geoffrey W. McCaughan, Darrell H.G. Crawford, William Sievert, Martin D. Weltman, Wendy S. Cheng, Stuart K. Roberts. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Journal of Hepatology 2013; 58(3): 467 doi: 10.1016/j.jhep.2012.11.017
|
| 83 |
In Hee Kim, Tatiana Kisseleva, David A. Brenner. Aging and liver disease. Current Opinion in Gastroenterology 2015; 31(3): 184 doi: 10.1097/MOG.0000000000000176
|
| 84 |
Cristin Grant. A vitamin D protocol post‐liver transplantation. Journal of the American Association of Nurse Practitioners 2017; 29(11): 658 doi: 10.1002/2327-6924.12503
|
| 85 |
Malcolm D. Kearns, Jessica A. Alvarez, Natan Seidel, Vin Tangpricha, Vin Tangpricha. Impact of Vitamin D on Infectious Disease. The American Journal of the Medical Sciences 2015; 349(3): 245 doi: 10.1097/MAJ.0000000000000360
|
| 86 |
Livia Melo-Villar, Elisabeth Lampe, Adilson J. de Almeida, Leticia de P. Scalioni, Lia L. Lewis-Ximenez, Juliana C. Miguel, José A. Del Campo, Isidora Ranchal, Cristiane A. Villela-Nogueira, Manuel Romero-Gomez. Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients. Annals of Hepatology 2015; 14(4): 457 doi: 10.1016/S1665-2681(19)31166-4
|
| 87 |
Fatmanur Zehra Zelka, Rümeysa Rabia Kocatürk, Öznur Özge Özcan, Mesut Karahan. Can Nutritional Supports Beneficial in Other Viral Diseases Be Favorable for COVID-19?. Korean Journal of Family Medicine 2022; 43(1): 3 doi: 10.4082/kjfm.20.0134
|
| 88 |
Fang Yuan, Ning Wang, Yan Chen, Xinping Huang, Zhen Yang, Yingying Xu, Kai You, Jiaye Zhang, Guodong Wang, Yuanqi Zhuang, Tingcai Pan, Yue Xiong, Xiaorui Yu, Fan Yang, Yinxiong Li. Calcitriol promotes the maturation of hepatocyte-like cells derived from human pluripotent stem cells. The Journal of Steroid Biochemistry and Molecular Biology 2021; 211: 105881 doi: 10.1016/j.jsbmb.2021.105881
|
| 89 |
Takuya Matsumura, Nao Sugiyama, Asako Murayama, Norie Yamada, Masaaki Shiina, Shinichi Asabe, Takaji Wakita, Michio Imawari, Takanobu Kato. Antimicrobial peptide LL‐37 attenuates infection of hepatitis C virus. Hepatology Research 2016; 46(9): 924 doi: 10.1111/hepr.12627
|
| 90 |
Lamiaa N. Hammad, Sahar M. Abdelraouf, Fetouh S. Hassanein, Walid A. Mohamed, Mona F. Schaalan. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis?. Journal of Immunotoxicology 2013; 10(4): 380 doi: 10.3109/1547691X.2012.758198
|
| 91 |
Milica Bjelakovic, Dimitrinka Nikolova, Goran Bjelakovic, Christian Gluud. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Systematic Reviews 2021; 2021(10) doi: 10.1002/14651858.CD011564.pub3
|
| 92 |
Harel Dahari, Shimon Shteingart, Inna Gafanovich, Scott J. Cotler, Massimo D'Amato, Ralf T. Pohl, Gali Weiss, Yaakov J. Ashkenazi, Thomas Tichler, Eran Goldin, Yoav Lurie. Sustained virological response with intravenous silibinin: individualized IFN‐free therapy via real‐time modelling of HCV kinetics. Liver International 2015; 35(2): 289 doi: 10.1111/liv.12692
|
| 93 |
Allen T. Griffin. Health of HIV Infected People. 2015; : 189 doi: 10.1016/B978-0-12-800769-3.00012-3
|
| 94 |
Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Leila Rahbarnia, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran. Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection 2021; 49(6): 1133 doi: 10.1007/s15010-021-01644-3
|
| 95 |
Imam Waked, Waheed Doss, Manal Hamdy El-Sayed, Chris Estes, Homie Razavi, Gamal Shiha, Ayman Yosry, Gamal Esmat. The current and future disease burden of chronic hepatitis C virus infection in Egypt. Arab Journal of Gastroenterology 2014; 15(2): 45 doi: 10.1016/j.ajg.2014.04.003
|
| 96 |
Mohamed El-Kassas, Abeer Awad. Metabolic aspects of hepatitis C virus. World Journal of Gastroenterology 2022; 28(22): 2429-2436 doi: 10.3748/wjg.v28.i22.2429
|
| 97 |
Benjamin Terrier, Nathanael Lapidus, Stanislas Pol, Lawrence Serfaty, Vlad Ratziu, Tarik Asselah, Vincent Thibault, Jean-Claude Souberbielle, Fabrice Carrat, Patrice Cacoub. Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study. World Journal of Gastroenterology 2015; 21(18): 5647-5653 doi: 10.3748/wjg.v21.i18.5647
|
| 98 |
Yasuteru Kondo, Takanobu Kato, Osamu Kimura, Tomoaki Iwata, Masashi Ninomiya, Eiji Kakazu, Masahito Miura, Takehiro Akahane, Yutaka Miyazaki, Tomoo Kobayashi, Motoyasu Ishii, Norihiro Kisara, Kumiko Sasaki, Haruo Nakayama, Takehiko Igarashi, Noriyuki Obara, Yoshiyuki Ueno, Tatsuki Morosawa, Tooru Shimosegawa, Makoto Makishima. 1(OH) Vitamin D3 Supplementation Improves the Sensitivity of the Immune-Response during Peg-IFN/RBV Therapy in Chronic Hepatitis C Patients-Case Controlled Trial. PLoS ONE 2013; 8(5): e63672 doi: 10.1371/journal.pone.0063672
|
| 99 |
Julia Beilfuss, Vivian Berg, Monica Sneve, Rolf Jorde, Elena Kamycheva. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 2012; 60(3): 870 doi: 10.1016/j.cyto.2012.07.032
|
| 100 |
Arthur Belle, Emmanuel Gizard, Guillaume Conroy, Anthony Lopez, Magali Bouvier‐Alias, Stéphanie Rouanet, Laurent Peyrin‐Biroulet, Jean‐Michel Pawlotsky, Jean‐Pierre Bronowicki. 25‐OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV‐infected patients. United European Gastroenterology Journal 2017; 5(1): 69 doi: 10.1177/2050640616640157
|
| 101 |
Л.Р. Шостакович-Корецкая, М.А. Николайчук, И.В. Будаева, О.П. Шевченко-Макаренко, В.Д. Ткаченко. Relationship between Vitamin D and Genotype, Fibrosis, Viral Load in Patients with Chronic Hepatitis C. Клиническая инфектология и паразитология 2020; (1): 71 doi: 10.34883/PI.2020.9.1.006
|
| 102 |
María Guzmán-Fulgencio, Mónica García-Álvarez, Juan Berenguer, Mª Ángeles Jiménez-Sousa, Jaime Cosín, Daniel Pineda-Tenor, Ana Carrero, Teresa Aldámiz, Emilio Álvarez, Juan Carlos López, Salvador Resino. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. Journal of Infection 2014; 68(2): 176 doi: 10.1016/j.jinf.2013.10.011
|
| 103 |
En-Qiang Chen, Ying Shi, Hong Tang. New insight of vitamin D in chronic liver diseases. Hepatobiliary & Pancreatic Diseases International 2014; 13(6): 580 doi: 10.1016/S1499-3872(14)60295-2
|
| 104 |
Ivan Gentile, Antonio Riccardo Buonomo, Federico Borgia, Emanuela Zappulo, Giuseppe Castaldo, Guglielmo Borgia. MK-5172: a second-generation protease inhibitor for the treatment of hepatitis C virus infection. Expert Opinion on Investigational Drugs 2014; 23(5): 719 doi: 10.1517/13543784.2014.902049
|
| 105 |
Luiza Vitelo Andrighetto, Jacqueline Shaurich Dos Santos, Graziella Nicoletti, Patricia Martins Bock. INFLUÊNCIA DA VITAMINA D ASSOCIADA AO INTERFERON ALFA PEGUILADO E RIBAVIRINA NA RESPOSTA VIROLOGICA SUSTENTADA NA HEPATITE C CRÔNICA. Infarma - Ciências Farmacêuticas 2016; 28(3): 140 doi: 10.14450/2318-9312.v28.e3.a2016.pp140-148
|
| 106 |
Pasquale Mansueto, Aurelio Seidita, Giustina Vitale, Sebastiano Gangemi, Chiara Iaria, Antonio Cascio. Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/735615
|
| 107 |
Danielle Venturini, Andréa Colado Simão, Isaias Dichi. Role of Oxidative Stress in Chronic Diseases. 2014; : 90 doi: 10.1201/b16653-8
|
| 108 |
Andrea D Branch, Minhee Kang, Kimberly Hollabaugh, Christina M Wyatt, Raymond T Chung, Marshall J Glesby. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. The American Journal of Clinical Nutrition 2013; 98(2): 423 doi: 10.3945/ajcn.112.048785
|
| 109 |
José M. Ladero, María J. Torrejón, Pilar Sánchez-Pobre, Avelina Suárez, Francisca Cuenca, Virginia de la Orden, María J. Devesa, María Rodrigo, Vicente Estrada, Gustavo López-Alonso, José A. Agúndez. Vitamin D deficiency and vitamin D therapy in chronic hepatitis C. Annals of Hepatology 2013; 12(2): 199 doi: 10.1016/S1665-2681(19)31357-2
|
| 110 |
Noemi Hernández-Alvarez, Juan Manuel Pascasio Acevedo, Enrique Quintero, Inmaculada Fernández Vázquez, María García-Eliz, Juan de la Revilla Negro, Javier Crespo García, Manuel Hernández-Guerra. Effect of season and sunlight on viral kinetics during hepatitis C virus therapy. BMJ Open Gastroenterology 2017; 4(1): e000115 doi: 10.1136/bmjgast-2016-000115
|
| 111 |
Jeremy T. Keane, Harendran Elangovan, Rebecca A. Stokes, Jenny E. Gunton. Vitamin D and the Liver—Correlation or Cause?. Nutrients 2018; 10(4): 496 doi: 10.3390/nu10040496
|
| 112 |
Rohit Thirumdas, Anjinelyulu Kothakota, R. Pandiselvam, Akbar Bahrami, Francisco J. Barba. Role of food nutrients and supplementation in fighting against viral infections and boosting immunity: A review. Trends in Food Science & Technology 2021; 110: 66 doi: 10.1016/j.tifs.2021.01.069
|
| 113 |
Matthew T. Kitson, Stuart K. Roberts. D-livering the message: The importance of vitamin D status in chronic liver disease. Journal of Hepatology 2012; 57(4): 897 doi: 10.1016/j.jhep.2012.04.033
|
| 114 |
Derek Yu, Jordan J Feld. HCV protease inhibitors: using the evidence to guide clinical practice. Clinical Investigation 2012; 2(9): 923 doi: 10.4155/cli.12.80
|
| 115 |
Chao-Nan Jin, Jing-Dan Chen, Ji-Fang Sheng. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?. European Journal of Gastroenterology & Hepatology 2018; 30(7): 741 doi: 10.1097/MEG.0000000000001134
|
| 116 |
Danijela Ristic-Medic, Snjezana Petrovic, Aleksandra Arsic, Vesna Vucic. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World Journal of Gastroenterology 2021; 27(34): 5682-5699 doi: 10.3748/wjg.v27.i34.5682
|
| 117 |
Ivan Gentile, Antonio Riccardo Buonomo, Guglielmo Borgia. Ombitasvir: a potent pan-genotypic inhibitor of NS5A for the treatment of hepatitis C virus infection. Expert Review of Anti-infective Therapy 2014; 12(9): 1033 doi: 10.1586/14787210.2014.940898
|
| 118 |
Saumya Singh, Prithwish Kola, Dalveer Kaur, Gisha Singla, Vibhu Mishra, Parmjit S. Panesar, Kumar Mallikarjunan, Meena Krishania. Therapeutic Potential of Nutraceuticals and Dietary Supplements in the Prevention of Viral Diseases: A Review. Frontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.679312
|
| 119 |
Walid A. Mohamed, Mona F. Schaalan, Hanan S. El-Abhar. Camel Milk: Potential Utility as an Adjunctive Therapy to Peg-IFN/RBV in HCV-4 Infected Patients in Egypt. Nutrition and Cancer 2015; 67(8): 1307 doi: 10.1080/01635581.2015.1087041
|
| 120 |
Gamal Esmat, Maissa El Raziky, Aisha Elsharkawy, Dina Sabry, Mohamed Hassany, Amal Ahmed, Noha Assem, Mohamad El Kassas, Wahid Doss. Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin. Journal of Interferon & Cytokine Research 2015; 35(1): 49 doi: 10.1089/jir.2014.0060
|
| 121 |
Midori Takeda, Masanori Ikeda, Kyoko Mori, Masahiko Yano, Yasuo Ariumi, Hiromichi Dansako, Takaji Wakita, Nobuyuki Kato. Raloxifene inhibits hepatitis C virus infection and replication. FEBS Open Bio 2012; 2(1): 279 doi: 10.1016/j.fob.2012.08.003
|
| 122 |
Mattias Mandorfer, Thomas Reiberger, Berit A. Payer, Arnulf Ferlitsch, Florian Breitenecker, Maximilian C. Aichelburg, Barbara Obermayer-Pietsch, Armin Rieger, Michael Trauner, Markus Peck-Radosavljevic. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV–hepatitis C virus coinfected patients. AIDS 2013; 27(2): 227 doi: 10.1097/QAD.0b013e32835aa161
|
| 123 |
Tatehiro Kagawa, Sei‐ichiro Kojima, Koichi Shiraishi, Shunji Hirose, Yoshitaka Arase, Shinji Takashimizu, Norihito Watanabe, Naruhiko Nagata, Makoto Numata, Hirokazu Shiozawa, Yasuhiro Nishizaki, Mayu Toki, Teruji Sugita, Kijuro Nomura, Takashi Sakaguchi, Kazuhiro Atsukawa, Hiroto Tajima, Yoshihiro Tei, Tsutomu Inomoto, Tetsuya Mine. Meloxicam as an adjuvant to peginterferon‐α‐2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial. Hepatology Research 2013; 43(9): 925 doi: 10.1111/hepr.12046
|
| 124 |
Cameron C. Grant, Suhina Kaur, Ellen Waymouth, Edwin A. Mitchell, Robert Scragg, Alec Ekeroma, Alistair Stewart, Julian Crane, Adrian Trenholme, Carlos A. Camargo. Reduced primary care respiratory infection visits following pregnancy and infancy vitamin D supplementation: a randomised controlled trial. Acta Paediatrica 2015; 104(4): 396 doi: 10.1111/apa.12819
|
| 125 |
Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Kai Yoshizawa, Hiroshi Abe, Toru Asano, Yusuke Ohkubo, Masahiro Araki, Tadashi Ikegami, Tomomi Okubo, Chisa Kondo, Yuji Osada, Katsuhisa Nakatsuka, Yoshimichi Chuganji, Yasushi Matsuzaki, Katsuhiko Iwakiri, Yoshio Aizawa. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. Hepatology Research 2016; 46(5): 450 doi: 10.1111/hepr.12575
|
| 126 |
Shahida Khan, Ashraf Ali, Sarah Khan, Ahmed Bakillah, Ghazi Damanhouri, Aziz Khan, Ahmed Makki, Ibtehal AlAnsari, Naheed Banu. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Nutrition & Metabolism 2018; 15(1) doi: 10.1186/s12986-018-0251-5
|
| 127 |
T. Kawaoka, M. Imamura, H. Kan, H. Fujino, T. Fukuhara, T. Kobayashi, Y. Honda, N. Naeshiro, A. Hiramatsu, M. Tsuge, C.N. Hayes, Y. Kawakami, H. Aikata, H. Ochi, K. Ishiyama, H. Tashiro, H. Ohdan, K. Chayama. Two Patients Treated With Simeprevir Plus Pegylated-Interferon and Ribavirin Triple Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation: Case Report. Transplantation Proceedings 2015; 47(3): 809 doi: 10.1016/j.transproceed.2014.10.052
|
| 128 |
Fabio Salvatore Macaluso, Marcello Maida, Maria Giovanna Minissale, Teresa Li Vigni, Simona Attardo, Emanuele Orlando, Salvatore Petta. Metabolic Factors and Chronic Hepatitis C: A Complex Interplay. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/564645
|
| 129 |
Rodolphe Anty, M Tonohouan, P Ferrari-Panaia, T Piche, A Pariente, Q M Anstee, P Gual, A Tran. Low Levels of 25-Hydroxy Vitamin D are Independently Associated with the Risk of Bacterial Infection in Cirrhotic Patients. Clinical and Translational Gastroenterology 2014; 5(5): e56 doi: 10.1038/ctg.2014.6
|
| 130 |
Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, Ai Nakagawa, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Hideko Kidokoro, Yoshiyuki Narahara, Katsuhisa Nakatsuka, Katsuhiko Iwakiri, Chiaki Kawamoto, Choitsu Sakamoto. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepatitis Monthly 2013; 13(12) doi: 10.5812/hepatmon.14872
|
| 131 |
Sami A. Gabr, Ahmad H. Alghadir, Chao Hung Hung. Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/6665893
|
| 132 |
Alessio Alesci, Angelo Fumia, Patrizia Lo Cascio, Anthea Miller, Nicola Cicero. Immunostimulant and Antidepressant Effect of Natural Compounds in the Management of Covid-19 Symptoms. Journal of the American Nutrition Association 2022; 41(8): 840 doi: 10.1080/07315724.2021.1965503
|
| 133 |
Xiaoqiong Duan, Yujuan Guan, Yujia Li, Shan Chen, Shilin Li, Limin Chen, Stuart Gray. Vitamin D Potentiates the Inhibitory Effect of MicroRNA‐130a in Hepatitis C Virus Replication Independent of Type I Interferon Signaling Pathway. Mediators of Inflammation 2015; 2015(1) doi: 10.1155/2015/508989
|
| 134 |
C. Wartelle‐Bladou, G. Le Folgoc, M. Bourlière, L. Lecomte. Hepatitis C therapy in non‐genotype 1 patients: the near future. Journal of Viral Hepatitis 2012; 19(8): 525 doi: 10.1111/j.1365-2893.2012.01634.x
|
| 135 |
Tetsuro Shimakami, Masao Honda, Takayoshi Shirasaki, Riuta Takabatake, Fanwei Liu, Kazuhisa Murai, Takayuki Shiomoto, Masaya Funaki, Daisuke Yamane, Seishi Murakami, Stanley M. Lemon, Shuichi Kaneko. The Acyclic Retinoid Peretinoin Inhibits Hepatitis C Virus Replication and Infectious Virus Release in Vitro. Scientific Reports 2014; 4(1) doi: 10.1038/srep04688
|
| 136 |
Filippo Ansaldi, Andrea Orsi, Laura Sticchi, Bianca Bruzzone, Giancarlo Icardi. Hepatitis C virus in the new era: Perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy. World Journal of Gastroenterology 2014; 20(29): 9633-9652 doi: 10.3748/wjg.v20.i29.9633
|
| 137 |
Yasuteru Kondo. Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment. World Journal of Gastroenterology 2017; 23(8): 1325-1327 doi: 10.3748/wjg.v23.i8.1325
|
| 138 |
Rui Yu, Deming Tan, Qin Ning, Junqi Niu, Xuefan Bai, Shijun Chen, Jun Cheng, Yanyan Yu, Hao Wang, Min Xu, Guangfeng Shi, Mobin Wan, Xinyue Chen, Hong Tang, Jifang Sheng, Xiaoguang Dou, Junping Shi, Hong Ren, Maorong Wang, Hongfei Zhang, Zhiliang Gao, Chengwei Chen, Hong Ma, Jidong Jia, Jinlin Hou, Qing Xie, Jian Sun. Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B. Hepatology Research 2018; 48(3) doi: 10.1111/hepr.12972
|
| 139 |
Steven J Weintraub, Jacquelyn F Fleckenstein, Tony N Marion, Margaret A Madey, Tahar M Mahmoudi, Kenneth B Schechtman. Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response. The American Journal of Clinical Nutrition 2012; 96(5): 1025 doi: 10.3945/ajcn.112.039974
|
| 140 |
Nghiem Xuan Hoan, Hoang Van Tong, Le Huu Song, Christian G Meyer, Thirumalaisamy P Velavan. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. World Journal of Gastroenterology 2018; 24(4): 445-460 doi: 10.3748/wjg.v24.i4.445
|
| 141 |
H.G. Ağalar. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. 2021; : 175 doi: 10.1016/B978-0-12-816488-4.00009-7
|
| 142 |
Azza A Eltayeb, Madleen Adel A Abdou, Amal M Abdel-aal, Mostafa H Othman. Vitamin D status and viral response to therapy in hepatitis C infected children. World Journal of Gastroenterology 2015; 21(4): 1284-1291 doi: 10.3748/wjg.v21.i4.1284
|
| 143 |
Hasan Vosoghinia, Abbas Esmaeilzadeh, Azita Ganji, Seyed Mousal-Reza Hosseini, Saeid Amel Jamehdar, Maryam Salehi, Ali Bahari, Omid Ghanaei, Maryam Sahebari, Farnood Rajabzadeh, Kamran Ghaffarzadehgan, Ladan Goshayeshi. Vitamin D in Standard HCV Regimen (PEG-Interferon Plus Ribavirin), Its Effect on the Early Virologic Response Rate: A Clinical Trial. Razavi International Journal of Medicine 2016; 4(2) doi: 10.17795/rijm36632
|
| 144 |
Masanori Atsukawa, Akihito Tsubota, Noritomo Shimada, Chisa Kondo, Norio Itokawa, Ai Nakagawa, Satomi Hashimoto, Takeshi Fukuda, Yoko Matsushita, Yoshiyuki Narahara, Katsuhiko Iwakiri, Katsuhisa Nakatsuka, Chiaki Kawamoto, Choitsu Sakamoto. Serum 25‐hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load. Hepatology Research 2014; 44(13): 1277 doi: 10.1111/hepr.12298
|
| 145 |
|
| 146 |
Karan Sud, Akhil Parashar, Veeraish Chauhan. Textbook of Nephro-Endocrinology. 2018; : 373 doi: 10.1016/B978-0-12-803247-3.00021-0
|
| 147 |
Pankaj Puri. Will Vitamin D Supplementation Have a Role in the Treatment of Patients with Chronic Hepatitis C?. Journal of Clinical and Experimental Hepatology 2012; 2(4): 396 doi: 10.1016/j.jceh.2012.10.008
|
| 148 |
Erikka Loftfield, Thomas R. O’Brien, Ruth M. Pfeiffer, Charles D. Howell, Ron Horst, Ludmila Prokunina-Olsson, Stephanie J. Weinstein, Demetrius Albanes, Timothy R. Morgan, Neal D. Freedman, Chien-Wei Su. Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials. PLOS ONE 2016; 11(11): e0166036 doi: 10.1371/journal.pone.0166036
|
| 149 |
Md. Tanvir Kabir, Md. Sahab Uddin, Md. Farhad Hossain, Jawaher A. Abdulhakim, Md. Asraful Alam, Ghulam Md Ashraf, Simona G. Bungau, May N. Bin-Jumah, Mohamed M. Abdel-Daim, Lotfi Aleya. nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00616
|
| 150 |
Ivan Gentile, Emanuela Zappulo, Antonio Riccardo Buonomo, Guglielmo Borgia. Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus. Expert Review of Anti-infective Therapy 2014; 12(7): 775 doi: 10.1586/14787210.2014.920254
|